Greenwich LifeSciences, Inc. 8-K Report: Key Insights & Stock Info

Based on the provided XML section of the financial report, here are the key insights extracted:
- Entity Information:
- Company Name: Greenwich LifeSciences, Inc.
- CIK (Central Index Key): 0001799788
- State of Incorporation: Delaware (DE)
- SEC File Number: 001-39555
- Employer Identification Number (EIN): 20-5473709
- Address:
- Location: 3992 Bluebonnet Dr, Building 14, Stafford, TX 77477
- Contact Number: (832) 819-3232
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: December 19, 2024
- Stock Information:
- Common Stock Par Value: $0.001
- Ticker Symbol: GLSI
- Exchange: NASDAQ
- Reporting Period:
- Report Date: The report pertains to the date December 19, 2024, indicating a snapshot or event report on that specific date.
- Units of Measurement:
- Currency: USD (United States Dollar)
- Shares: The report includes measures relating to shares, though specific share amounts are not provided in this excerpt.
Summary:
The financial report provides an overview of Greenwich LifeSciences, Inc., including its basic corporate information, details about its current stock, and the specific reporting date for the 8-K filing. This information is crucial for investors and stakeholders monitoring the company's compliance and performance in the market.